Please do not adjust margins
Page 1 of 8
New Journal of Chemistry
1
2
3
4
5
6
7
DOI: 10.1039/D0NJ01229G
ARTICLE
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Synthesis and Characterization of new Heterocycles related to
Aryl[e][1,3]diazepinediones. Rearrangement to 2,4-Diamino-1,3,5-
triazine Derivatives.
Received 00th January 20xx,
Accepted 00th January 20xx
c
d
Rostyslav Bardovskyi, a Oleksandr Grytsai,b Cyril Ronco* and Rachid Benhida*
DOI: 10.1039/x0xx00000x
ABSTRACT: Novel non-planar heterocycles make a great contribution to drug design and medicinal chemistry. Fused
aryl[e][1,3]diazepinediones are a less investigated and appealing class of compounds. Herein, we designed 5 types of
polynitrogen containing compounds based on 3-aminobenzo[e][1,3]diazepine-1,5-dione and undescribed 3-
aminopyrido[3,4-e][1,3]diazepine-1,5-dione, 7-aminopyrido[2,3-e][1,3]diazepine-5,9-dione and 7-aminopyrazino[2,3-
e][1,3]diazepine-5,9-dione. The synthesis, characterization, chemical properties, and X-ray structures are presented.
Stability studies led to the identification of a novel rearrangement of 2-guanidino-benzo[e][1,3]diazepine-4,7-dione to 2,4-
diamino-6-phenyl-1,3,5-triazines by hydrolytic ring-opening followed by cyclocondensation. This reactivity has been used to
efficiently access, after optimization, an “activated” 2,2,2-trifluoroester, which was successively transformed into variously
functionalized derivatives by hydrolysis, transesterification or amide formation. These latter structures present high
potential as precursors of drug-like molecules.
combining both features, biguanide and benzodiazepinedione
cores (molecules of type C, Figure 2), is highly appealing to
consider hybrid/dual molecules.
Herein, we present several original classes of molecules
based on 3-amino-benzo[e][1,3]diazepine-1,5-dione1, and we
report the syntheses of three new heterocycles, namely 7-
Introduction
The fused aryl[e][1,3]diazepinediones are an original
heterocyclic scaffold. It shows attractivestructural features
with a favorable balance between size, rigidity, and number of
potential H-bonding sites. Moreover, related fused
aryldiazepine derivatives are present in well-known drugs, as
demonstrated by the successful family of benzo[1,4]
diazepin(on)es that efficiently inhibit GABA receptors in the
central nervous system,1 and were proposed recently for other
biomedical applications.2 5-Member-ring fused diazepinediones
are mainly represented by imidazole-fused or 1,2,3-triazole-
fused structures used as purine extended analogs. Among these
compounds, some molecules show interesting inhibition of
several viruses by targeting NTPase and helicase enzymes, while
other derivatives exert modest cytotoxic effects against certain
cancer cell lines.3–7 On the other hand, to the best of our
knowledge, there are almost no reports of 6-member-ring fused
diazepinediones, which are basically restricted to only two
examples.8,9 Furthermore, the pyridine- and pyrazine-fused 1,3-
diazepinedione scaffolds are unknown from the literature yet
(Figure 1).
amino-pyrido[2,3-e][1,3]diazepine-5,9-dione
pyrido[3,4-e][1,3]diazepine-1,5-dione 3, 2-amino-pyrido[3,4-
e][1,3]diazepine-4,7-dione and 7-amino-pyrazino[2,3-
2,
3-amino-
e][1,3]diazepine-5,9-dione 4, as well as analogs thereof. In total,
28 new derivatives have been prepared and fully characterized
(Figure 2). The structural properties, solubility and stability
profiles and X-ray crystal structures of representative
compounds were studied. In addition, a rearrangement by
cyclocondensation of bisamidine derivatives toward
phenyltriazines was remarkably observed, which was then
extended through several representative examples.
New heterocycles
O
O
O
N
N
NH
N
NH
N
NH
N
NH2
NH2
NH2
N
N
O
O
O
4
2
3
Recently, biguanide derivatives have received increasing
attention because of their potent pharmacological properties in
line with metformin and its analogs, which have many clinical
applications in metabolic and cancer diseases.10 Therefore,
7-amino-5H-pyrazino[2,3-e]
[1,3]diazepine-5,9(6H)-dione
7-amino-5H-pyrido[2,3-e]
[1,3]diazepine-5,9(6H)-dione [1,3]diazepine-1,5(2H)-dione
3-amino-1H-pyrido[3,4-e]
Figure 1. New heterocycles based on fused aryl[e][1,3]diazepinediones.
a, b, c, d. Université Côte d’Azur, CNRS, Institut de Chimie de Nice UMR 7272, 06108,
Nice, France.
c.
d.
* corresponding authors
Please do not adjust margins